Back to results
US 7,610,097 B2Granted
Electromagnetic stimulation in patients with osteoporosis
OwnerRichard Markollinventor
Life of this patent
Estimating the term…
Abstract
Provided is the combined use of pulsating electromagnetic signals and dose of Botulinum toxin to treat patients suffering from osteoporosis. Also provided is the use of electromagnetic signals generated by pulsating, impulse-modulated direct current for the treatment of osteoporosis.
Claims20
Method for treating osteoporosis in a patient, comprising:
- exposing the patient to electromagnetic signals generated by pulsating, impulse-modulated direct current, having a frequency of 1 to 30 Hz and a field strength of 1 to 20 G;
- and
- administering Botulinum toxin to the patient, wherein the Botulinum toxin synergistically interacts with the electromagnetic signals, by inducing a non-specific immune response to further enhance a bone density stimulation from the exposure of the patient to the electromagnetic signals.
Method for administering a treatment to a patient including administration of a neurotoxin, the method comprising:
- providing a pharmaceutical composition comprising Botulinum toxin;
- administering the Botulinum toxin to the patient intramuscularly, intravenously, or subcutaneously;
- and
- exposing the patient to electromagnetic signals generated by pulsating, pulse-modulated, unidirectional, direct current, with frequency between 1 and 30 Hz and field strength, 1 to 20 G, wherein the Botulinum toxin synergistically interacts with the electromagnetic signals, by inducing a non-specific immune response to further enhance a bone density stimulation from the exposure of the patient to the electromagnetic signals.
1 more element
Dependencies are inferred from the claim text.